User talk:Amolpimpale000

Your submission at Articles for creation: International Journal in Pharmaceutical Sciences (May 2)
 Your recent article submission to Articles for Creation has been reviewed! Unfortunately, it has not been accepted because it included copyrighted content, which is not permitted on Wikipedia.

You are welcome to write an article on the subject, but please do not use copyrighted work.


 * Draft:International Journal in Pharmaceutical Sciences may be deleted at any time unless the copied text is removed. Copyrighted work cannot be allowed to remain on Wikipedia.
 * If you need any assistance, you can ask for help at the [//en.wikipedia.org/w/index.php?title=Wikipedia:WikiProject_Articles_for_creation/Help_desk&action=edit&section=new&nosummary=1&preload=Template:AfC_decline/HD_preload&preloadparams%5B%5D=User_talk:Amolpimpale000 Articles for creation help desk] or on the [//en.wikipedia.org/w/index.php?title=User_talk:Greenman&action=edit&section=new&nosummary=1&preload=Template:AfC_decline/HD_preload&preloadparams%5B%5D=User_talk:Amolpimpale000 reviewer's talk page] . or use Wikipedia's real-time chat help from experienced editors.

Greenman (talk) 18:24, 2 May 2023 (UTC)

Hello, Amolpimpale000. We welcome your contributions, but if you have an external relationship with the people, places or things you have written about on Wikipedia, you may have a conflict of interest (COI). Editors with a conflict of interest may be unduly influenced by their connection to the topic. See the conflict of interest guideline and FAQ for organizations for more information. We ask that you:


 * avoid editing or creating articles about yourself, your family, friends, colleagues, company, organization, clients, or competitors;
 * propose changes on the talk pages of affected articles (you can use the request edit template);
 * disclose your conflict of interest when discussing affected articles (see Conflict of interest);
 * avoid linking to your organization's website in other articles (see Spam);
 * do your best to comply with Wikipedia's content policies.

In addition, you are required by the Wikimedia Foundation's terms of use to disclose your employer, client, and affiliation with respect to any contribution which forms all or part of work for which you receive, or expect to receive, compensation. See Paid-contribution disclosure.

Also, editing for the purpose of advertising, publicising, or promoting anyone or anything is not permitted. JBW (talk) 19:08, 2 May 2023 (UTC)

International Journal in Pharmaceutical Sciences moved to draftspace
Thanks for your contributions to International Journal in Pharmaceutical Sciences. Unfortunately, I do not think it is ready for publishing at this time because it has no sources. I have converted your article to a draft which you can improve, undisturbed for a while.

Please see more information at Help:Unreviewed new page. When the article is ready for publication, please click on the "Submit your draft for review!" button at the top of the page OR move the page back. microbiology Marcus (petri dish·growths) 00:45, 29 December 2023 (UTC)

December 2023
Hello Amolpimpale000. The nature of your edits, such as the one you made to Draft:International Journal in Pharmaceutical Sciences, gives the impression you have an undisclosed financial stake in promoting a topic, but you have not complied with Wikipedia's mandatory paid editing disclosure requirements. Paid advocacy is a category of conflict of interest (COI) editing that involves being compensated by a person, group, company or organization to use Wikipedia to promote their interests. Undisclosed paid advocacy is prohibited by our policies on neutral point of view and what Wikipedia is not, and is an especially serious type of COI; the Wikimedia Foundation regards it as a "black hat" practice akin to black-hat search-engine optimization.

Paid advocates are strongly discouraged from direct article editing, and should instead propose changes on the talk page of the article in question if an article exists. If the article does not exist, paid advocates are strongly discouraged from attempting to write an article at all. At best, any proposed article creation should be submitted through the articles for creation process, rather than directly.

Regardless, if you are receiving or expect to receive compensation for your edits, broadly construed, you are  required by the Wikimedia Terms of Use to disclose your employer, client and affiliation. You can post such a mandatory disclosure to your user page at User:Amolpimpale000. The template Paid can be used for this purpose – e.g. in the form:. If I am mistaken – you are not being directly or indirectly compensated for your edits – please state that in response to this message. Otherwise, please provide the required disclosure. In either case, do not edit further until you answer this message. DoubleGrazing (talk) 07:42, 29 December 2023 (UTC)

You still have not adequately responded or taken action to the inquiry regarding your appearance as an undisclosed paid editor. If you make any additional edits without complying, you may be blocked from editing. DoubleGrazing (talk) 18:44, 30 December 2023 (UTC)


 * Dear DoubleGrazing, I am a paid editor for this article. This is unbiased and true information i have written for this page. Kindly tell me in detail what neccesaru vchanges I should do, if you found any queries within the page. Amolpimpale000 (talk) 19:33, 30 December 2023 (UTC)
 * You are required to formally disclose your paid-editing status, as instructed above. Thank you. -- DoubleGrazing (talk) 20:36, 30 December 2023 (UTC)

== Your submission at Articles for creation: International Journal in Pharmaceutical Sciences (December 29) ==  Your recent article submission to Articles for Creation has been reviewed. Unfortunately, it has not been accepted at this time. The reason left by 94rain was:

The comment the reviewer left was:

Please check the submission for any additional comments left by the reviewer. You are encouraged to edit the submission to address the issues raised and resubmit after they have been resolved.


 * If you would like to continue working on the submission, go to Draft:International Journal in Pharmaceutical Sciences and click on the "Edit" tab at the top of the window.
 * If you do not edit your draft in the next 6 months, it will be considered abandoned and may be deleted.
 * If you need any assistance, or have experienced any untoward behavior associated with this submission, you can ask for help at the [//en.wikipedia.org/w/index.php?title=Wikipedia:WikiProject_Articles_for_creation/Help_desk/New_question&withJS=MediaWiki:AFCHD-wizard.js&page=Draft:International_Journal_in_Pharmaceutical_Sciences Articles for creation help desk], on the [//en.wikipedia.org/w/index.php?title=User_talk:94rain&action=edit&section=new&nosummary=1&preload=Template:AfC_decline/HD_preload&preloadparams%5B%5D=Draft:International_Journal_in_Pharmaceutical_Sciences reviewer's talk page] or use Wikipedia's real-time chat help from experienced editors.

94rain Talk  07:44, 29 December 2023 (UTC)

== Your submission at Articles for creation: International Journal in Pharmaceutical Sciences (December 29) ==  Your recent article submission to Articles for Creation has been reviewed. Unfortunately, it has not been accepted at this time. The reason left by DoubleGrazing was:

The comment the reviewer left was:

Please check the submission for any additional comments left by the reviewer. You are encouraged to edit the submission to address the issues raised and resubmit after they have been resolved.


 * If you would like to continue working on the submission, go to Draft:International Journal in Pharmaceutical Sciences and click on the "Edit" tab at the top of the window.
 * If you do not edit your draft in the next 6 months, it will be considered abandoned and may be deleted.
 * If you need any assistance, or have experienced any untoward behavior associated with this submission, you can ask for help at the [//en.wikipedia.org/w/index.php?title=Wikipedia:WikiProject_Articles_for_creation/Help_desk/New_question&withJS=MediaWiki:AFCHD-wizard.js&page=Draft:International_Journal_in_Pharmaceutical_Sciences Articles for creation help desk], on the [//en.wikipedia.org/w/index.php?title=User_talk:DoubleGrazing&action=edit&section=new&nosummary=1&preload=Template:AfC_decline/HD_preload&preloadparams%5B%5D=Draft:International_Journal_in_Pharmaceutical_Sciences reviewer's talk page] or use Wikipedia's real-time chat help from experienced editors.

DoubleGrazing (talk) 07:45, 29 December 2023 (UTC)

Speedy deletion nomination of Draft:International Journal in Pharmaceutical Sciences


A tag has been placed on Draft:International Journal in Pharmaceutical Sciences, requesting that it be speedily deleted from Wikipedia. This has been done under section G11 of the criteria for speedy deletion, because the page seems to be unambiguous advertising which only promotes a company, group, product, service, person, or point of view and would need to be fundamentally rewritten in order to become encyclopedic. Please read the guidelines on spam and FAQ/Organizations for more information.

If you think this page should not be deleted for this reason, you may contest the nomination by visiting the page and clicking the button labelled "Contest this speedy deletion". This will give you the opportunity to explain why you believe the page should not be deleted. However, be aware that once a page is tagged for speedy deletion, it may be deleted without delay. Please do not remove the speedy deletion tag from the page yourself, but do not hesitate to add information in line with Wikipedia's policies and guidelines. If the page is deleted, and you wish to retrieve the deleted material for future reference or improvement, then please contact the. Randykitty (talk) 10:26, 31 December 2023 (UTC)

December 2023
 You have been blocked indefinitely from editing because your account is being used only for advertising or promotion. If you think there are good reasons for being unblocked, please review Wikipedia's guide to appealing blocks, then add the following text to the bottom of your talk page:. Jimfbleak - talk to me? 11:19, 31 December 2023 (UTC)